ADDF Joins BIRAX Regenerative Medicine Initiative


The Alzheimer's Drug Discovery Foundation (ADDF) has joined the BIRAX Initiative, which recently issues its third call for proposals. BIRAX brings together British and Israeli scientists to tackle some of the world’s most challenging diseases including cardiovascular and liver disease, diabetes and Parkinson’s. 

PsychoGenics and the ADDF Announce a Risk-Sharing Partnership for Preclinical Studies


We are partnering with PsychoGenics Inc. to bring its services to our grantees working on preclinical Alzheimer’s drug discovery programs. 

Five New Research Grants Support Clinical and Early-Stage Programs


Funded Researchers Are Pursuing Diverse Targets to Treat Alzheimer's Disease

New Members Deepen Research & Investment Expertise of ADDF Boards


At the December joint meeting, the ADDF Boards of Governors and Overseers welcomed seven new members.

Margaret and Daniel Loeb Honored at Our Sixth Annual Fall Symposium & Luncheon


On Monday, November 9, Margaret and Daniel Loeb received The Charles Evans Award from the Alzheimer’s Drug Discovery Foundation (ADDF) at our Sixth Annual Fall Symposium & Luncheon “Hope on the Horizon” at The Pierre in New York City.  Thanks to the generosity of our donors, the Symposium & Luncheon raised more than $1 million, the most in the event’s history. All proceeds support the ADDF’s mission to accelerate the discovery and development of drugs to prevent, treat and cure Alzheimer’s disease.             

New Grant Supports Alzecure’s Work on Neurorestorative Drug


AlzeCure Foundation announced today that it has been awarded a grant from the Alzheimer’s Drug Discovery Foundation (ADDF) to support the further development of its small molecule neurorestorative project.

Dr. Frank Longo Wins Inaugural Melvin R. Goodes Prize


Dr. Longo’s Pioneering Approach May Soon Lead to New Disease Modifying Drugs 

Register Today for the Hope Flies Health Series Webinar


The Foundation for Mitochondrial Medicine (FMM) is hosting its Hope Flies Health Series Webinar: Research Connecting Alzheimer’s and Mitochondrial Disease on Wednesday, September 23, 2015 at 12:00 pm EST. The Foundation developed the webinar with partners including the Alzheimer’s Drug Discovery Foundation (ADDF), MitoAction and Sharecare to particularly bring greater awareness to mitochondrial disease in conjunction with Global Mitochondrial Disease Awareness Week, beginning September 21. 

ADDF and Harrington Discovery Institute Announce 2015 Award Recipients


Collaboration Advances Development of Therapeutics for the Treatment of Alzheimer’s Disease

ADDF to be Featured in Upcoming Episode of Innovations with Ed Begley Jr.


The ADDF will be featured in an upcoming episode of Innovations with Ed Begley Jr., airing via Discovery Channel later this year. 

Go to top